The covid-19 pandemic exposed how state and local governments’ severely outdated technology can hinder unemployment benefits, food stamps, Medicaid, vaccine registrations, and the flow of other critical information. Now, with hefty federal pandemic relief and unexpected tax windfalls, states may finally have the chance to revamp their information technology for health care and social services. But can they?
Say you’re on Day 6 — or 8 or 10 — of a symptomatic covid infection, and a rapid antigen test comes back positive. Could the test just be detecting bits and pieces of dead virus? If you’re a petri dish, sure. But if you’re a human, chances are you’re still infectious. Virologists weigh in.
Omicron infections are surging in residential care facilities, causing massive sickouts among staff members and an uptick in hospitalizations and deaths. The latest visitor restrictions and testing requirements are also compounding the isolation that residents have suffered for almost two years.
The omicron variant upended a system in which states shared rapid covid tests with those that needed them more. Cooperation has turned into competition as states run out of supplies, limit which organizations get them, or hold on to expired kits as a last resort.
With its highest-in-the-nation vaccination rates, Vermont offers a glimpse of what’s possible as the U.S. learns to live with coronavirus.
If federal officials accept a court’s decision, some patients will get a chance to seek refunds for their nursing home and other expenses.
Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of “The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having — Or Being Denied — An Abortion.”
Mass General Brigham’s $2.3 billion expansion plan is raising state officials’ concerns that it will reduce competition and raise the price of care in Massachusetts. It also signals a national shift from a focus on hospital mergers and purchases of physician practices — which boost the cost of care — to individual hospitals’ expansions to gain a bigger share of the market.
KHN gives readers a chance to comment on a recent batch of stories.
The health agency and the White House acted in the wake of a KHN story about pharmacists refusing to give shots to patients with moderate to severe immune suppression.
